We are live on
!
Find out more
Pacira BioSciences
PCRX
PCRX
156 hedge funds and large institutions have $1.37B invested in Pacira BioSciences in 2018 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 57 increasing their positions, 54 reducing their positions, and 29 closing their positions.
New
Increased
Maintained
Reduced
Closed
100% more funds holding in top 10
Funds holding in top 10: 2 → 4 (+2)
6% more repeat investments, than reductions
Existing positions increased: 57 | Existing positions reduced: 54
1% more capital invested
Capital invested by funds: $1.36B → $1.37B (+$9.8M)
2.13% less ownership
Funds ownership: 107.43% → 105.3% (-2.1%)
7% less funds holding
Funds holding: 168 → 156 (-12)
38% less first-time investments, than exits
New positions opened: 18 | Existing positions closed: 29
56% less call options, than puts
Call options by funds: $12.2M | Put options by funds: $27.6M
Holders
156
Holders Change
-12
Holders Change %
-7.14%
% of All Funds
3.57%
Holding in Top 10
4
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+100%
% of All Funds
0.09%
New
18
Increased
57
Reduced
54
Closed
29
Calls
$12.2M
Puts
$27.6M
Net Calls
-$15.5M
Net Calls Change
+$487K
Top Buyers
| 1 |
PHS
PFM Health Sciences
San Francisco,
California
|
+$48.5M |
| 2 |
CCM
Consonance Capital Management
New York
|
+$38.6M |
| 3 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
+$26.5M |
| 4 |
HM
HealthCor Management
New York
|
+$19.2M |
| 5 |
ECP
Elk Creek Partners
Denver,
Colorado
|
+$12.7M |
Top Sellers
| 1 |
Westfield Capital Management
Boston,
Massachusetts
|
-$26M |
| 2 |
AC
Armistice Capital
New York
|
-$22.6M |
| 3 |
EIP
Epoch Investment Partners
New York
|
-$21.9M |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
-$20.2M |
| 5 |
Jennison Associates
New York
|
-$16M |
